Altered glutamate receptor function in the cerebellum of the Ppt1 -/- mouse, a murine model of infantile neuronal ceroid lipofuscinosis

Journal of Neuroscience Research

Volumn 90, Issue 2, 2012, Pages 367-375

  Finn, Rozzy ^a,b   Kovács, Attila D ^a   Pearce, David A ^a,b,c  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

^c UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Ampa; Batten disease; Cln1; Nmda; Ppt1

Indexed keywords

AMPA RECEPTOR; GLUTAMATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PALMITOYL PROTEIN THIOESTERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CEREBELLUM; CONTROLLED STUDY; GENE MUTATION; GRANULE CELL; MALE; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CEREBELLUM; CROSS-LINKING REAGENTS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURONAL CEROID-LIPOFUSCINOSES; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; THIOLESTER HYDROLASES;

EID: 83155180398     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22763     Document Type: Article

References (53)

1. Ahtiainen L, Kolikova J, Mutka AL, Luiro K, Gentile M, Ikonen E, Khiroug L, Jalanko A, Kopra O. 2007. Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction. Neurobiol Dis 28: 52-64.
2. Aldridge GM, Podrebarac DM, Greenough WT, Weiler IJ. 2008. The use of total protein stains as loading controls: an alternative to high-abundance single-protein controls in semi-quantitative immunoblotting. J Neurosci Methods 172: 250-254.
3. Aras MA, Hartnett KA, Aizenman E. 2008. Assessment of cell viability in primary neuronal cultures. Curr Protoc Neurosci, Chapter 7, Unit 7 18.
4. Boudreau AC, Wolf ME. 2005. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J Neurosci 25: 9144-9151.
5. Camp LA, Hofmann SL. 1993. Purification and properties of a palmitoyl-protein thioesterase that cleaves palmitate from H-Ras. J Biol Chem 268: 22566-22574.
6. Camp LA, Verkruyse LA, Afendis SJ, Slaughter CA, Hofmann SL. 1994. Molecular cloning and expression of palmitoyl-protein thioesterase. J Biol Chem 269: 23212-23219.
7. 3H)-dione derivative (S)-CPW399 as a novel, potent, and subtype-selective AMPA receptor full agonist with partial desensitization properties. J Med Chem 44: 4501-4504.
8. Chattopadhyay S, Pearce DA. 2000. Neural and extraneural expression of the neuronal ceroid lipofuscinoses genes CLN1, CLN2, and CLN3: functional implications for CLN3. Mol Genet Metab 71: 207-211.
9. Chen BS, Roche KW. 2007. Regulation of NMDA receptors by phosphorylation. Neuropharmacology 53: 362-368.
10. Cho S, Dawson G. 1998. Enzymatic and molecular biological analysis of palmitoyl protein thioesterase deficiency in infantile neuronal ceroid lipofuscinosis. J Neurochem 71: 323-329.
11. Collingridge GL, Isaac JT, Wang YT. 2004. Receptor trafficking and synaptic plasticity. Nat Rev Neurosci 5: 952-962.
12. Conrad KL, Tseng KY, Uejima JL, Reimers JM, Heng LJ, Shaham Y, Marinelli M, Wolf ME. 2008. Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving. Nature 454: 118-121.
13. Cooper JD. 2003. Progress towards understanding the neurobiology of Batten disease or neuronal ceroid lipofuscinosis. Curr Opin Neurol 16: 121-128.
14. Finn R, Kovacs AD, Pearce DA. 2010. Altered sensitivity to excitotoxic cell death and glutamate receptor expression between two commonly studied mouse strains. J Neurosci Res 88: 2648-2660.
15. Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM, Wentz AE, Cooper JD, Sands MS. 2006. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. Mol Ther 13: 538-547.
16. Griffin JL, Muller D, Woograsingh R, Jowatt V, Hindmarsh A, Nicholson JK, Martin JE. 2002. Vitamin E deficiency and metabolic deficits in neuronal ceroid lipofuscinosis described by bioinformatics. Physiol Genomics 11: 195-203.
17. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL. 2001. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. Proc Natl Acad Sci U S A 98: 13566-13571.
18. Hachiya Y, Hayashi M, Kumada S, Uchiyama A, Tsuchiya K, Kurata K. 2006. Mechanisms of neurodegeneration in neuronal ceroid-lipofuscinoses. Acta Neuropathol 111: 168-177.
19. Hashimoto K, Fukaya M, Qiao X, Sakimura K, Watanabe M, Kano M. 1999. Impairment of AMPA receptor function in cerebellar granule cells of ataxic mutant mouse stargazer. J Neurosci 19: 6027-6036.
20. Hayashi T, Thomas GM, Huganir RL. 2009. Dual palmitoylation of NR2 subunits regulates NMDA receptor trafficking. Neuron 64: 213-226.
21. Hellsten E, Vesa J, Olkkonen VM, Jalanko A, Peltonen L. 1996. Human palmitoyl protein thioesterase: evidence for lysosomal targeting of the enzyme and disturbed cellular routing in infantile neuronal ceroid lipofuscinosis. EMBO J 15: 5240-5245.
22. Iizuka M, Nishimura S, Wakamori M, Akiba I, Imoto K, Barsoumian EL. 2000. The lethal expression of the GluR2flip/GluR4flip AMPA receptor in HEK293 cells. Eur J Neurosci 12: 3900-3908.
23. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL, Salonen T, Rapola J, Gentile M, Kopra O, Peltonen L. 2005. Mice with Ppt1Deltaex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiol Dis 18: 226-241.
24. Jensen P, Surmeier DJ, Goldowitz D. 1999. Rescue of cerebellar granule cells from death in weaver NR1 double mutants. J Neurosci 19: 7991-7998.
25. Johansen TH, Chaudhary A, Verdoorn TA. 1995. Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors. Mol Pharmacol 48: 946-955.
26. Kadotani H, Hirano T, Masugi M, Nakamura K, Nakao K, Katsuki M, Nakanishi S. 1996. Motor discoordination results from combined gene disruption of the NMDA receptor NR2A and NR2C subunits, but not from single disruption of the NR2A or NR2C subunit. J Neurosci 16: 7859-7867.
27. Kew JN, Kemp JA. 2005. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology 179: 4-29.
28. Kielar C, Wishart TM, Palmer A, Dihanich S, Wong AM, Macauley SL, Chan CH, Sands MS, Pearce DA, Cooper JD, Gillingwater TH. 2009. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease. Hum Mol Genet 18: 4066-4080.
29. Kohr G. 2006. NMDA receptor function: subunit composition vs. spatial distribution. Cell Tissue Res 326: 439-446.
30. Kovacs AD, Pearce DA. 2008. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease. Exp Neurol 209: 288-291.
31. Kovacs AD, Cebers G, Cebere A, Moreira T, Liljequist S. 2001. Cortical and striatal neuronal cultures of the same embryonic origin show intrinsic differences in glutamate receptor expression and vulnerability to excitotoxicity. Exp Neurol 168: 47-62.
32. Kovacs AD, Weimer JM, Pearce DA. 2006. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease. Neurobiol Dis 22: 575-585.
33. Lehtovirta M, Kyttala A, Eskelinen EL, Hess M, Heinonen O, Jalanko A. 2001. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum Mol Genet 10: 69-75.
34. Leveille F, El Gaamouch F, Gouix E, Lecocq M, Lobner D, Nicole O, Buisson A. 2008. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors. FASEB J 22: 4258-4271.
35. Liu Y, Peterson DA, Kimura H, Schubert D. 1997. Mechanism of cellular 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69: 581-593.
36. Lu JY, Verkruyse LA, Hofmann SL. 1996. Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase. Proc Natl Acad Sci U S A 93: 10046-10050.
37. Lu JY, Verkruyse LA, Hofmann SL. 2002. The effects of lysosomotropic agents on normal and INCL cells provide further evidence for the lysosomal nature of palmitoyl-protein thioesterase function. Biochim Biophys Acta 1583: 35-44.
38. Macauley SL, Wozniak DF, Kielar C, Tan Y, Cooper JD, Sands MS. 2009. Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Exp Neurol 217: 124-135.
39. Michaelis EK. 1998. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging. Prog Neurobiol 54: 369-415.
40. Page KJ, Everitt BJ. 1995. The distribution of neurons coexpressing immunoreactivity to AMPA-sensitive glutamate receptor subtypes (GluR1-4) and nerve growth factor receptor in the rat basal forebrain. Eur J Neurosci 7: 1022-1033.
41. Partin KM, Patneau DK, Mayer ML. 1994. Cyclothiazide differentially modulates desensitization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor splice variants. Mol Pharmacol 46: 129-138.
42. Partin KM, Fleck MW, Mayer ML. 1996. AMPA receptor flip/flop mutants affecting deactivation, desensitization, and modulation by cyclothiazide, aniracetam, and thiocyanate. J Neurosci 16: 6634-6647.
43. 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease. J Biol Chem 280: 42508-42514.
44. Seitz D, Grodd W, Schwab A, Seeger U, Klose U, Nagele T. 1998. MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis. AJNR Am J Neuroradiol 19: 1373-1377.
45. Sen N, Snyder SH. 2010. Protein modifications involved in neurotransmitter and gasotransmitter signaling. Trends Neurosci 33: 493-502.
46. 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3. J Neurosci Res 77: 762-769.
47. Sleat DE, Sohar I, Lackland H, Majercak J, Lobel P. 1996. Rat brain contains high levels of mannose-6-phosphorylated glycoproteins including lysosomal enzymes and palmitoyl-protein thioesterase, an enzyme implicated in infantile neuronal lipofuscinosis. J Biol Chem 271: 19191-19198.
48. Sornarajah L, Vasuta OC, Zhang L, Sutton C, Li B, El-Husseini A, Raymond LA. 2008. NMDA receptor desensitization regulated by direct binding to PDZ1-2 domains of PSD-95. J Neurophysiol 99: 3052-3062.
49. Suopanki J, Lintunen M, Lahtinen H, Haltia M, Panula P, Baumann M, Tyynela J. 2002. Status epilepticus induces changes in the expression and localization of endogenous palmitoyl-protein thioesterase 1. Neurobiol Dis 10: 247-257.
50. Verkruyse LA, Hofmann SL. 1996. Lysosomal targeting of palmitoyl-protein thioesterase. J Biol Chem 271: 15831-15836.
51. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L. 1995. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature 376: 584-587.
52. Wang JQ, Liu X, Zhang G, Parelkar NK, Arora A, Haines M, Fibuch EE, Mao L. 2006. Phosphorylation of glutamate receptors: a potential mechanism for the regulation of receptor function and psychostimulant action. J Neurosci Res 84: 1621-1629.
53. Watanabe D, Inokawa H, Hashimoto K, Suzuki N, Kano M, Shigemoto R, Hirano T, Toyama K, Kaneko S, Yokoi M, Moriyoshi K, Suzuki M, Kobayashi K, Nagatsu T, Kreitman RJ, Pastan I, Nakanishi S. 1998. Ablation of cerebellar Golgi cells disrupts synaptic integration involving GABA inhibition and NMDA receptor activation in motor coordination. Cell 95: 17-27.